Staufen1 is a component of transported ribonucleoprotein complexes. Genetic work in Drosophila has suggested that Staufen plays a role in the de-repression of translation of oskar mRNA following localization. To determine whether Staufen1 can play a similar role in mammals, we studied translation of transcripts in the presence or in the absence of Staufen1. Translationally repressed mRNAs were generated by fusing the structured human immunodeficiency virus type 1 trans-activating response (TAR) element to the 5 0 end of a reporter transcript. In rabbit reticulocyte lysates and in mammalian cultured cells, the addition of Staufen1 resulted in the up-regulation of reporter activity when translation was driven by the TAR-bearing RNA. In contrast, Staufen1 had no effect on translation of efficiently translated mRNAs lacking an apparent structured 5 0 end, suggesting that Staufen1-binding to the 5 0 end is required for enhanced translation. Consistently, Staufen1 RNA-binding activity is necessary for this translational effect. In addition, similar up-regulation of translation was observed when Staufen1 was tethered to the 5 0 end of mRNAs via other structured RNAs, the highest level of translational increase being obtained with the bona fide Staufen1-binding site of the Arf1 transcript. The expression of Staufen1 promoted polysomal loading of TAR-luciferase transcripts resulting in enhanced translation. Our results support a model in which the expression of Staufen1 and its interaction with the 5 0 end of RNA and ribosomes facilitate translation initiation.
ABSTRACT
Staufen1 is a component of transported ribonucleoprotein complexes. Genetic work in Drosophila has suggested that Staufen plays a role in the de-repression of translation of oskar mRNA following localization. To determine whether Staufen1 can play a similar role in mammals, we studied translation of transcripts in the presence or in the absence of Staufen1. Translationally repressed mRNAs were generated by fusing the structured human immunodeficiency virus type 1 trans-activating response (TAR) element to the 5 0 end of a reporter transcript. In rabbit reticulocyte lysates and in mammalian cultured cells, the addition of Staufen1 resulted in the up-regulation of reporter activity when translation was driven by the TAR-bearing RNA. In contrast, Staufen1 had no effect on translation of efficiently translated mRNAs lacking an apparent structured 5 0 end, suggesting that Staufen1-binding to the 5 0 end is required for enhanced translation. Consistently, Staufen1 RNA-binding activity is necessary for this translational effect. In addition, similar up-regulation of translation was observed when Staufen1 was tethered to the 5 0 end of mRNAs via other structured RNAs, the highest level of translational increase being obtained with the bona fide Staufen1-binding site of the Arf1 transcript. The expression of Staufen1 promoted polysomal loading of TAR-luciferase transcripts resulting in enhanced translation. Our results support a model in which the expression of Staufen1 and its interaction with the 5 0 end of RNA and ribosomes facilitate translation initiation.
INTRODUCTION
Intracellular localization of mRNA is a universal phenomenon that is conserved in plants and animals (1) (2) (3) . It has been shown to be important for cell motility (4), asymmetric cell division (5) , axis formation during development (6) , synaptic plasticity (7) and long-term potentiation (8) . One general concept that emerges from studies on mRNA localization is the link that exists between localization and translation (3, 9) . mRNA is translationally silent during transport, but its translation becomes de-repressed following transport, resulting in localized protein synthesis. While several mechanisms to achieve translational repression during transport have been described, these largely involve the association of a repressor to the 3 0 -untranslated region (3 0 -UTR) (10) (11) (12) (13) (14) or the presence of an inhibitory RNA structure in the 5 0 -UTR to block translational initiation (15, 16) .
In contrast, there are few details known about the mechanism that controls the de-repression of translation following mRNA transport. Work in Drosophila has suggested that RNA-binding proteins can play a role here. For example, Staufen is a double-stranded RNA (dsRNA)-binding protein (17) that is required for the de-repression of oskar mRNA translation in oocytes (10, 18) . The mechanism underlying this function of Staufen is not known. In mammals, Staufen1 (Stau1 55 ) (19, 20) is a component of RNA transport granules and ribosome-free RNA particles (21, 22) . It is believed to play important role(s) in the transport of RNA to dendrites (23) (24) (25) and because it is also associated with polysomes (19, 20, (26) (27) (28) , it is likely to be involved in the translation of mRNAs.
To address the role of Staufen1 in translation, we used the well-studied model of translational repression involving the human immunodeficiency virus type 1 (HIV-1) transactivating response region (TAR). The TAR RNA sequence is present at the 5 0 end of all HIV-1 transcripts and forms a stable secondary RNA structure consisting of a stem-loop with a bulge. It inhibits translation by making the RNA cap structure inaccessible to translation initiation factors (29) and more generally by activating the interferon response pathway (15, 30, 31) . In addition to the viral protein Tat (32) , many cellular factors, including the dsRNA-dependent kinase (PKR) (33) , the TAR-RNA-binding protein (TRBP) (34) , the RNA helicase A (RHA) (35) and the La autoantigen (36) , have been shown to interact with the RNA TAR structure. Some of these proteins also regulate translation of TAR-containing transcripts. PKR becomes activated when bound to TAR (15, 31) . Activated PKR phosphorylates the translation initiation factor 2a (eIF-2a) thus causing general inhibition of translation (37) (38) (39) (40) . In contrast, TRBP which was identified in a large-scale screen for cellular TAR interacting proteins (34) partially relieves the TAR-induced inhibition of translation through a PKR-independent pathway (41) . Similarly, the La autoantigen stimulates translation of TAR-bearing transcripts through its ATP-dependent helicase activity that disrupts the TAR secondary structure (42, 43) .
In this report, we studied the role of Stau1 55 in translation in both rabbit reticulocyte lysates (RRLs) and in human embryonic kidney (HEK)293T cells. To generate translationally repressed transcripts, we fused dsRNA structures to the 5 0 end of reporter transcripts. Our studies show that Stau1 55 stimulates translation of structure-repressed mRNA in a mechanism that requires Stau1 55 -binding to the 5 0 end of transcripts. Therefore, Staufen1 expression and binding are important factors to regulate translation of some RNAs and to contribute to the de-repression of translation following mRNA localization.
MATERIALS AND METHODS

Antibodies and reagents
Mouse polyclonal anti-ribosomal L7/SPA protein antibodies were obtained from Novus Biologicals (Littleton, CO), mouse monoclonal anti-tubulin antibodies from ICN (Aurora, OH), rabbit polyclonal anti-calnexin antibodies from Stressgen Biotechnologies (Victoria, BC, Canada) and anti-mouse and anti-rabbit polyclonal antibodies conjugated to horseradish peroxidase from DakoCytomation (Mississauga, ON, Canada). To generate Stau1 55 monoclonal antibodies, bacterially expressed human GST-Stau1 55 D2 was affinity purified on a glutathione Sepharose matrix (Amersham Biosciences Corp, Piscataway, NJ) and eluted from the column by cleavage with thrombin. Mice were injected with 10 mg of antigen per injection. Following serum conversion, spleens of positive mice were isolated and monoclonal antibodies (11C6) were prepared as described previously (44) . G418 and 2-aminopurine (2-AP) were purchased from Sigma (Oakville, ON, Canada).
cDNA construction
Plasmids coding for Stau1 55 D2-his 6 (formerly named HFBDQ-his 6 ), NEP-his 6 , Stau1 55 -HA 3 (20) and Stau1 55F -HA 3 (26) were described previously. Plasmids containing mutations in TAR were generated from the p48 (pCD, pEF, pGH and pIJ) or p49 (pAB) plasmids (generous gifts from K. T. Jeang, NIH/NIAID Bethesda, MD) by ligation of double-stranded synthetic oligonucleotides (Table 1) within the TAR sequence. The p48 and p49 plasmids were first digested with SmaI/EcoRI and AvaI/EcoRI, respectively, treated with the Klenow fragment to blunt ends and ligated to remove the SacI restriction site in the multi-cloning site. Then, plasmids were digested with Sac1 in the TAR sequence and either BamH1 (pAB), BglII (pCD) or HindIII (pEF, pGH and pIJ), purified and ligated with oligonucleotides. La-his 6 plasmid was obtained by subcloning the BamHI/HindIII fragment of La-pBS SK (a generous gift from K. T. Jeang) in frame with the his 6 tag in the pQE31 expressing plasmid (Qiagen, Mississauga, ON, Canada). pcDNA3 RSV-Rluc plasmid was constructed by subcloning the HindIII-XbaI PCR fragment from pRluc-N1(h) (PerkinElmer Biosignal Inc, Montreal, QC, Canada) into the XbaI-HindIII sites of pcDNA3 RSV plasmid (45) . The PCR was carried out with 2 U of Vent DNA polymerase (New England Biolabs, Pickering, ON, Canada) and the sense 5 0 -CTCACGCGTCTGCAG-3 0 and antisense 5 0 -GGCTGATTATGCTCTAGATCG-3 0 primers. The pcDNA3 RSV-TAR-Rluc plasmid was constructed by subcloning the TAR-containing HindIII fragment of pSp6TAR-CAT plasmid (a generous gift from E. Cohen, University of Montreal) into the HindIII site of pcDNA3 RSVRluc. The sh1 and sh2 plasmids were obtained by the PCR SHAGging strategy (46) . Two rounds of PCR were carried out. A first PCR was carried out on the pGEM-U6 plasmid (a generous gift from G. Ferbeyre, University of Montreal) with 50 pmol of U6 sense 5 0 -GATTTAGGTGACACTATAG-3 (95  C for 3 min, 30 cycles at 95  C for 30 s, 55  C for 30 s,  72 C for 1 min, followed by a 10 min incubation at 72 C). PCR products were purified on low-melt agarose gel, and ethanol precipitated. They were then cloned as followed: using the first PCR SHAG products as template, a second PCR amplification was carried out with 0.2 mM of U6 sense 5 0 -ACAGAATTCGATTTAGGTGACACTATAG-3
0
(underlined: the EcoRI restriction site) and sh1 antisense 5 0 -ACACTCGAGAAAAAAATAAGGATCAACAGGCTTA-3 0 (underlined: the XhoI restriction site) or sh2 antisense 
Recombinant protein production and purification
Bacterially expressed Stau1
55 D2-his 6 and NEP-his 6 were induced for 3 h with 1 mM isopropyl-b-D-thiogalactopyranoside and purified as described previously (20) . Aliquots of purified proteins were stored at À80 C until use. Protein concentration was determined by the BioRad dye reagent and BSA as standard.
In vitro assays
The SpIII-10 CAT and pSp64TAR-CAT plasmids (generous gift from E. Cohen, University of Montreal) were linearized at the BamHI site, transcribed in vitro using the Sp6 RNA polymerase and m7GpppG CAP analog and used for in vitro translation in RRLs as described previously (42) . One-fifth volume of CAT and one volume of TAR-CAT translation products were either loaded on gel and detected by autoradiography or quantified by enzyme-linked immunosorbent assay (ELISA) as indicated by the manufacturer (Roche Biochemicals, Laval, QC, Canada). For the in vitro ribosome pull-down assay, 250 ng of Stau1 55 D2-his 6 , in the presence or in the absence of 50 ng of TAR-CAT RNA, were incubated with RRL for 1 h. The reaction mixture was diluted to 300 ml with ice-cold isotonic buffer (110 mM KOAc, 2 mM MgOAc, 10 mM HEPES-KOH, pH 7.3 and 2 mM DTT) and centrifuged in a Beckman SW 50.1C rotor for 45 min at 100 000 g at 4 C. The ribosome-enriched pellet was harvested and analysed by SDS-PAGE. The helicase assay was performed as described previously (43) . Northwestern and filter binding assays were carried as described previously (20) . For immunoprecipitation, transfected cells were lysed in 600 ml of lysis buffer (50 mM Tris-Cl, pH 7.5, 0.5% Triton X-100, EDTA 15 mM and DTT 1 mM). Cells extracts were precleared with 60 ml of 50% v/v Protein A-Sepharose slurry (Roche) for 1 h and then incubated with 3 ml of anti-HA ascite fluid (12CA5) at 4 C for 2 h and with 150 ml of 50% v/v Protein A-Sepharose slurry at 4 C for 2 h.
RNA steady-state level HEK293T cells were cultured in 12-well dishes and transfected with 100 ng of pcDNA3 RSV-Rluc or pcDNA3 RSV-TAR-Rluc in the absence or in the presence of increasing quantities of pcDNA3 RSV-Stau1 55 -HA 3 with FuGene6 transfection reagent (Roche). Twenty-four hours post-transfection, total RNA was extracted with Trizol reagent (Invitrogen Life Science, Burlington, ON, Canada) and treated with DNase I for 1 h at 37 C. Rluc, TAR-Rluc and GAPDH RNAs were reverse transcribed at 42 C for 17 min using 1 mg of total RNA, 5 pmol of Rluc (5 0 -CAGCACTCTCTCCACGAAGC-3 0 ) and GAPDH (5 0 -CAAAAGTTGTCATGGATGACC-3 0 ) antisense primers using the GENEAMP RNA PCR core kit (Applied Biosystems, Foster City, CA). Rluc (5 0 -GCAAGGT-GTACGACCCCG-3 0 ) and GAPDH (5 0 -CCTTCATTGACCT-CAACTACAT-3 0 ) sense primers (250 ng) were added for PCR amplification (95 C for 2 min, followed by 17 cycles at 94 C for 1 min, 54 C for 1 min and 72 C for 1 min). Resulting products were resolved on a 1.25% agarose gel. Similarly, 50 ng of CAT or TAR-CAT RNAs were incubated with RRL at 30 C for 0, 7.5, 15 or 30 min in the presence of 40 mg/ml of G418. RNA was extracted with Trizol reagent and reverse transcribed using 5 pmol of CAT antisense primer (5 0 -CCACTCATCGCAGTACTGTTG-3 0 ). PCRs were carried out at 95 C for 2 min, followed by 14 cycles at 94 C for 1 min, 52.5 C for 1 min and 72 C for 1 min using 250 ng of CAT sense primer (5 0 -CCTATAACCAGACCGTTCAGC-3 0 ) and antisense primer (5 0 -CCACTCATCGCAGTACTGTTG-3 0 ). Resulting products were resolved on a 1.5% agarose gel.
Transfection and luciferase assays
HEK293T cells and PKR
À/À MEF (a generous gift from A. Gatignol, McGill University) were cultured in DMEM (Invitrogen Life Science) supplemented with 10% Cosmic calf serum (Hyclone, Logan, UT), 5 mg/ml of penicillinstreptomycin and 2 mM L-Glutamine (Invitrogen Life Science). To test the role of Stau1 in translation, cells were transfected with FuGene6 (Roche Biochemicals) using 100 ng of pcDNA3 RSV-Rluc or pcDNA3 RSV-TAR-Rluc and increasing concentrations (0, 50, 100 and 500 ng) of plasmid coding for Stau1 55 -HA 3 or its mutants. Total amount of transfected DNA was adjusted to 600 ng with the pcDNA3 RSV plasmid. Cells were harvested 24 h post-transfection in 100 ml of lysis buffer (0.1 M Tris-Cl, pH 7.9, 0.5% NonidetP40 and 1 mM DTT) for 5 min on ice. An aliquot of 25 ml of the extracts and 5 mM Coelenterazine H (Molecular Probes, Burlington, ON, Canada) were used for Renilla reniformis luciferase assays. Luminescence was quantified with a Fusion a-FP (PerkinElmer-Canberra Packard BioScience) by measuring emitted light at 475-480 nm. To knockdown the expression of Stau1, HEK293T cells were transfected with Lipofectamine 2000 (Invitrogen Life Science) using 700 ng of the silencing sh1 or the non-silencing sh2 plasmids. For translation assays, cells were re-transfected 24 h later using FuGene6 (Roche) and plasmid DNA as described above. Knockdown rescue was performed with 300 ng of plasmid coding for Stau1 55 Dsh1-HA 3 .
Cell fractionation on sucrose gradients
Polyribosome profile was analysed as described previously (26) . Briefly, transfected HEK293T cells were incubated for 20 min with cycloheximide (100 mg/ml), washed in cold phosphate-buffered saline and isotonic buffer and lysed in hypotonic buffer supplemented with cycloheximide (100 mg/ml). For the run-off experiments, cells were incubated for 30 min with sodium azide (25 mM) instead of cycloheximide. Cytoplasmic extracts (corresponding to $20 OD 260 ) were centrifuged on a continuous 10-40% or 15-45% sucrose gradient containing 100 mM KCl, 10 mM KOAc, 2 mM MgOAc, 1 mM DTT and 5 mM HEPES-KOH, pH 7.3, with or without cycloheximide (100 mg/ml) in a SW41 rotor (Beckman) at 160 000 g for 150 min at 4 C. Fourteen fractions of $800 ml were recovered and the ribosomal profile was monitored at OD 254 with a gradient fractionator (ISCO, Lincoln, USA). Aliquots containing 25 ml of each fraction were analysed by SDS-PAGE and western blotting. For RNA analysis, total RNA was extracted from a 250 ml aliquot of each fraction by adding an equal volume of denaturing buffer [7 M urea, 1% (w/v) SDS, 350 mM NaCl, 10 mM EDTA and 10 mM Tris-HCl, pH 7.5] followed by phenol-chloroform extraction and ethanol precipitation. RNA samples were incubated for 5 min at 65 C in RNA denaturing solution [66% (v/v) formamide, 8% (w/v) formaldehyde, 1· MOPS electrophoresis buffer] and slot-blotted onto nylon membrane using a HybriSlot apparatus (Gibco BRL). Membranes were hybridized with a random-prime 32 Plabelled Rluc DNA fragment, exposed overnight and revealed by autoradiography.
RESULTS
Stau1 55 stimulates translation of inefficiently translated transcripts in RRL
To determine whether Stau1 55 regulates translation, we first set-up an in vitro translation assay using RRLs. Translation efficiencies of capped chloramphenicol acetyl transferase (CAT) RNA and TAR-CAT RNA ( Figure 1A ) were compared. Similar to previous data (29, 47) , the translation of a transcript that contains TAR at the 5 0 end is repressed in RRL ( Figure 1B ). Then, bacterially expressed and purified Stau1 55 D2-his 6 or NEP-his 6 as control ( Figure 1C ) were tested for their capacity to associate with ribosomes as reported in cultured cells (26) . Stau1 55 D2-his 6 was used instead of the fulllength Stau1 55 because this protein is more soluble than fulllength. RRLs were incubated in the presence or in the absence of 250 ng of recombinant Stau1 55 D2-his 6 and extracts were centrifuged at 100 000 g for 45 min to pellet ribosomes. Ribosomal pellets were separated by SDS-PAGE and analysed by western blotting using anti-Stau1 and anti-L7 ribosomal protein antibodies. After centrifugation, recombinant Stau1 55 D2-his 6 was found in the pellet with endogenous Stau1 and ribosomes ( Figure 1D ). The addition of TAR-CAT RNA had no effect on Staufen quantities in the ribosomal pellet, consistent with our previous demonstration that Stau1 interaction with ribosomes is RNA independent (26) . When centrifuged in the absence of RRL, Stau1 55 D2-his 6 was not detected in the pellet ( Figure 1D ). These results show that purified Stau1 55 D2-his 6 associates with ribosomes in RRL in the presence or in the absence of added RNAs and that it is not over-represented as compared with endogenous Stau1 in this assay.
RRLs were then incubated with CAT or TAR-CAT transcripts (4 mg/ml). At this RNA concentration, the translation capacity of RRL was not saturated and a 17-fold repression of translation of the TAR-CAT RNA was observed as compared with translation of CAT RNA ( Figure 1B ). Increasing concentrations of recombinant Stau1 55 D2-his 6 or NEP-his 6 were tested for their ability to stimulate translation. Stau1 55 D2-his 6 enhanced translation of the repressed TAR-CAT RNA in a dose-dependent manner reaching 15-fold ( Figure 1E ). This effect was specific since NEP-his 6 had no effect on TAR-CAT RNA translation. In contrast, Stau1 55 D2-his 6 did not markedly affect translation efficiency of CAT RNA, showing a 2-fold increase ( Figure 1E ). A sensitive CAT ELISA was also used to quantify the in vitro synthesis of CAT. These assays demonstrated that Stau1 55 D2-his 6 increases translation of TAR-repressed transcripts by 10-fold and that of normally translated mRNAs by only 2-fold ( Figure 1F ).
Stau1 55 stimulates translation of TAR-containing transcripts in mammalian cells
The effects of Staufen on translation efficiency were then measured in mammalian HEK293T cells. Cells were transfected with plasmids that expressed either Renilla reniformis luciferase (Rluc) or TAR-Rluc transcripts. The TARmediated translational repression was also observed in this context showing a 2-fold decrease in luciferase activity as compared with that of the Rluc transcript (Figure 2A) . HEK293T cells were then co-transfected with increasing amounts of Stau1 55 -HA 3 expressor construct ( Figure 2B ) and either Rluc or TAR-Rluc plasmids. As shown in Figure 2A , Stau1 55 -HA 3 stimulated translation of TAR-Rluc RNA 2-fold when compared with TAR-Rluc RNA translation in the absence of transfected Stau1 55 -HA 3 . In contrast, it had no effect on translation of Rluc transcript as indicated by a stable luciferase activity. Therefore, Stau1 55 -HA 3 rescued the inhibition imposed by the TAR sequence on the translation of TAR-Rluc transcripts. Importantly, the optimal amount of plasmid (100 ng) that enhances translation of TAR-Rluc mRNA results in Stau1 55 -HA 3 expression levels that are quantitatively close to that of endogenous Stau1 55 , as shown in Figure 2B .
In order to examine the effect of Staufen on translation, we then used RNAi to knockdown Staufen expression on HEK293T cells expressing the Rluc transcripts as above. Short hairpin (sh) RNA-expressing plasmids ( Figure 2C ) were used to knockdown endogenous expression of Stau1. sh1 was shown to result in a 92% decrease in Stau1 protein expression ( Figure 2D ). Therefore, sh1-(silencing) or control sh2-(non-silencing) expressing plasmids were co-transfected with plasmids that expressed either Rluc or TAR-Rluc. Sh1 caused a significant 30% decrease (P < 0.05) in luciferase activity in cells expressing the TAR-Rluc transcript ( Figure 2E ). In contrast, sh1 had no effect on luciferase activity when the Rluc transcript was expressed. sh2 did not modulate luciferase activity when either RNA was expressed ( Figure 2E ). In an attempt to demonstrate that the effect of Staufen on translation was indeed due to Staufen, we performed an experiment in which sh1 was used to knockdown expression of endogenous Staufen, but co-expresssed Staufen in trans using a vector that does not have the sh1 target sequence (Stau1 55 Dsh1-HA 3 , M. Luo and L. DesGroseillers, unpublished data) ( Figure 2C and D) . The results showed that the effects were specific to Staufen expression ( Figure 2E ). Taken together, the results obtained from three different approaches show that Stau1 55 modulates the expression of translationally repressed TAR-containing transcripts but has no effect on efficiently translated mRNAs. 
Stau1 55 -dependent translational stimulation is independent of PKR activity
The ability of Stau1 55 to modulate the expression of TARrepressed transcripts was distinguished from a competition with PKR for binding the dsRNA TAR structure by in vitro translation assay in the presence of 2-AP, a Ser/Thr kinase inhibitor (48) . As shown before (49), 2-AP treatment of RRL slightly increased translation of the TAR-CAT transcript 2-fold likely by relieving a partial translational repression imposed by PKR. However, increasing concentrations of Stau1 55 D2-his 6 still stimulated translation of the TARcontaining transcript 8-fold. This shows that 2-AP did not prevent Stau1 55 -dependent activation of translation ( Figure 3A and B) . In contrast, 2-AP prevented the 2-fold induction observed with Stau1 55 D2-his 6 on CAT RNA translation ( Figure 3A and B) , showing that, in this case, the increase in translation that is mediated by Staufen may be PKR dependent.
To confirm these results, we tested the effects of Stau1 55 in PKR-deficient cells (PKR À/À ) (50) . PKR À/À cells were cotransfected with plasmids coding for Stau1 55 -HA 3 and either Rluc or TAR-Rluc. As observed in HEK293T cells, Stau1 55 -HA 3 increased translation of TAR-Rluc mRNA by 2-fold, whereas it has no effect on Rluc transcripts ( Figure 3C ). Altogether, our results show that the Stau1 55 -stimulating effect on TAR-bearing RNA translation is achieved through a PKR-independent pathway.
Stau1
55 binds to the TAR RNA structure
We next determined whether Stau1 55 binds the TAR RNA structure in vitro since it is the only difference between the Rluc and TAR-Rluc transcripts. Filter binding and Northwestern assays (20) were used to examine this. These analyses have allowed us to show that Stau1 55 D2-his 6 binds the TAR-RNA structure with high affinity with a K d of 3.5 nM ( Figure 4A ).
Several mutants that disrupt specific regions of the TAR structure ( Figure 4B ) (34) were tested to map the Stau1 55 D2-his 6 binding site. Although mutations in the lower stem, in the bulge or in the loop did not abolish binding of Stau1 55 D2-his 6 , mutations in the upper stem between the bulge and the loop were critical ( Figure 4A and C) . As control, NEP-his 6 did not bind TAR RNA (data not shown). Altogether, these results support a model in which Stau1 55 D2-his 6 binds to the TAR RNA structure and this may be important for the observed translational enhancement of RNAs that possess structured 5 0 regions. 
Stau1 55 RNA-binding activity is required for TAR-induced translational activation
Since Stau1 55 binds the TAR RNA structure at the 5 0 end of the TAR-Rluc transcript, we then tested whether Stau1 55 binding to RNA is required for the observed up-regulation of TAR-Rluc translation. Two mutants, Stau1 55F -HA 3 (26) or Stau1 55KK -HA 3 (C. Martel and L. DesGroseillers, manuscript submitted) ( Figure 5A ), were first tested for their capacity to bind the TAR RNA structure in vitro. Northwestern assays using immunoprecipitated proteins isolated from HEK293T cells showed that, in contrast to Stau1 55 -HA 3 , both mutants were impaired in their RNA-binding activity ( Figure 5B) . Then, HEK293T cells were co-transfected with plasmids coding for either Stau1 55F -HA 3 or Stau1 55KK -HA 3 and with either TAR-Rluc or Rluc vectors. Western blot analysis showed that the levels of expression of the mutated proteins were quite similar to that of Stau1 55 -HA 3 ( Figure 5C ). However, these two mutants failed to stimulate the activity of either reporter ( Figure 5D ). In the same experiment, Stau1 55 -HA 3 stimulated translation of TAR-luciferase RNA 2-fold. These results suggest that Stau1 55 binding to RNA is critical for enhanced translation of TAR-containing transcripts.
The effects of Stau1 55 are at the level of translation
Three non-exclusive mechanisms may explain how Stau1 55 modulates translation of TAR-bearing transcripts: (i) increase in stability of TAR-containing RNA, (ii) unwinding activity of Stau1 on the TAR structure and/or (iii) direct binding to ribosomes or to translation factors and modulation of their activity.
To distinguish between an effect on TAR-bearing mRNA itself and an effect on the translational machinery, we assessed the ability of Stau1 55 to act at the level of RNA metabolism. To address this possibility, TAR-CAT and CAT mRNAs were incubated in RRL in the presence or in the absence of Stau1 55 D2-his 6 . An inhibitor of translation (G418) was added to prevent mRNA association/protection with translating ribosomes. Aliquots were taken at different time points and RT-PCR amplifications were carried out using primers in the CAT sequence. The presence of Stau1 55 D2-his 6 , or that of BSA as control, did not affect TAR-CAT ( Figure 6A ) or CAT (data not shown) mRNA stability, indicating that the RNA is as stable as in control conditions. Similarly, we tested whether the steady-state levels of TARRluc and Rluc mRNAs in HEK293T cells varied with overexpression of Stau1 55 -HA 3 . TAR-Rluc or Rluc expressing plasmids were co-transfected with increasing concentrations of Stau1 55 -HA 3 cDNAs. Twenty-four hours post-transfection, total RNA was extracted and semi-quantitative RT-PCR assays were performed using primers in the Rluc sequence. mRNA levels were normalized to endogenous gapdh mRNA. Expression of Stau1 55 -HA 3 did not affect the steady-state levels of TAR-Rluc and Rluc mRNAs ( Figure 6B ). Luciferase assays performed on the same cell extracts showed the expected increase in translation of TAR-Rluc RNA (data not shown). Figure 6C (right panel), a helicase activity was observed with the La autoantigen but could not be detected in the Stau1 55 D2-his 6 preparation. These results show that Stau1 55 D2-his 6 does not have helicase activity in vitro. These results suggest that Stau1 likely acts on the translational machinery to enhance structured RNA translation.
The Stau1
55 mutants that are unable to increase translation cofractionate with polysomes Since Stau1 55 associates with ribosomes (19, 26) , it might facilitate the positioning of the TAR-bearing transcript on the ribosomes and/or directly modulate ribosome activity. Therefore, one reason that Stau1 55 mutants failed to increase translation ( Figure 5D ) might be because the introduced mutations impaired their capacity to associate with ribosomes. We next determined whether ribosomes that are associated with the Stau1 55 mutants have impaired translational capability, e.g. by forming non-translating polysomes. To explore this possibility, centrifugation experiments were repeated following treatment with sodium azide, a non-specific inhibitor of translation initiation (51) . In this assay, mRNA-bound ribosomes are able to complete translation of the bound RNA but free ribosomes are unable to initiate translation. As a result, large polysomes disappear and the amounts of free ribosomes or ribosomal subunits increase. Following sodium azide treatment, large amounts of both Stau1 55 -HA 3 and Stau1 55 -HA 3 mutants were shifted from fractions containing heavy polysomes to fractions of monosomes and small polysomes ( Figure 7B) . Quantitation of the amounts of Stau1 55 -HA 3 , Stau1 55F -HA 3 and Stau1 55KK -HA 3 in the presence or in the absence of sodium azide revealed a reduction of 54.0, 54.4 and 58.8%, respectively, in the association with heavy polysomes. These results demonstrate that the mutations did not impair the capacity of the mutated Stau1 55 proteins to bind actively translating polysomes. Although we do not exclude the possibility that the mutations prevent association with essential translation factors, these results suggest that Stau1 acts as a carrier to facilitate transport/positioning of target RNAs on translating ribosomes.
Stau1 55 overexpression causes a shift of TAR-containing transcripts to dense polysomes
In order to determine how Stau1 was influencing the TARRluc RNA profile in polysomes, cells were transfected with plasmids expressing TAR-Rluc or Rluc, in the absence or in the presence of plasmids coding for Stau1 55 -HA 3 . In the absence of Stau1 55 -HA 3 , the TAR-Rluc RNA was mostly found in fractions corresponding to 80S ribosomes and light polysomes that contain few ribosomes ( Figure 8A ). However, in the presence of Stau1 55 -HA 3 , the TAR-Rluc RNA was shifted to heavy polysome fractions. In contrast, the Rluc RNA was found in heavy polysome fractions, in both the presence and absence of co-transfected Stau1 55 -HA 3 ( Figure 8B ). Interestingly, in the presence of Stau1 55 -HA 3 , the percentage of TAR-Rluc RNA in heavy polysome fractions was roughly the same as that of Rluc RNA in the presence or in the absence of Stau1 55 -HA 3 , consistent with the synthesis of similar amounts of Rluc protein (see above). These results suggest that Stau1 55 increases the probability to initiate TAR-Rluc RNA translation, thus increasing the number of attached ribosomes to form heavier polysomes and enhancing the global rate of translation of this transcript.
Stau1 increases translation of structure-repressed transcripts when tethered at the 5 0 end
To establish a correlation between Stau1 binding to the 5 0 end of transcripts and its ability to enhance translation, we substituted the TAR-RNA structure with other structured RNA sequences. The SBS that was recently identified by us (52) or two copies of the MS2 binding site (MS2bs) were fused to the 5 0 end of the Rluc transcript ( Figure 9A ). First, HEK293T cells were co-transfected with a fixed amount of either Rluc or SBS-Rluc cDNA and increasing amounts of cDNA coding for Stau1 55 -HA 3 . As shown in Figure 9B , Stau1 Figure 9D ) showing that the effect is specific to Staufen1. Importantly, co-transfection of Stau1 55 -HA 3 (instead of MS2-Stau1 55 -HA 3 ) did not increase translation of the MS2-Rluc transcript ( Figure 9D) showing that Stau1 55 recruitment to the structured 5 0 end of RNA is critical for increased translation of these RNAs.
DISCUSSION
In this paper, we show that Stau1 55 increases translation of mRNAs when bound to their 5 0 end. Consequently, Stau1 55 is not a general regulator of translation but rather acts on specific mRNA targets, through direct binding to their 5 0 end. Indeed, our data establish a significant correlation between the binding of Stau1 55 to the 5 0 end of a transcript and its ability to enhance translation. Interestingly, a maximal increase of expression was observed when a natural SBS (52) for TRBP on TAR-bearing RNAs (41) and for proteins of the exon-junction complex on MS2-containing RNAs (53) . In both the RRL assays in vitro and following transfection of cultured cells, the ratio of recombinant to endogenous Stau1 55 proteins associated with ribosomes and necessary to observe an effect on translation of TAR-bearing mRNAs is quite similar. In both cases, the amount of recombinant Stau1 55 that is required for optimal stimulation of translation is about onefifth the level of the endogenous Stau1 55 ( Figures 1D and 2B ). Therefore, it suggests that within a cell a slight variation in the expression of endogenous Stau1 55 may regulate the translation of Stau1 55 -bound mRNAs. Physiologically relevant transcripts harbouring structured 5 0 end are likely to be translationally repressed in the cells due to the translational block imposed by these structures (15, 16) . Therefore, their regulated interaction with Stau1 55 would allow a concerted expression of a specific set of Stau1 55 -bound transcripts in response to cell's needs (see below).
Other RNA-binding proteins have been shown to bind the TAR RNA structure and affect translation of TAR-bearing transcripts. Since both TRBP (34, 41) and La antoantigen (42) were shown to increase translation of TAR-bearing RNA, as does Stau1 55 , an indirect mechanism of translational repression involving competition between these proteins for the TAR RNA structure can be excluded. Inhibition of their function through competition should rather repress translation of TAR-bearing transcripts. In contrast, PKR activation through RNA binding was shown to repress translation (33), we show that the Stau1 55 -mediated increase in translation of TAR-bearing RNA is independent of PKR both in vitro and in cell cultures (Figure 3) 55 has no observable effect on RNA metabolism. It was suggested that the secondary structure of TAR affects translation by preventing the accessibility of the cap structure (29) . In this context, Stau1 55 may favour access of this highly structured RNA to the ribosomal and/or translational machinery. Binding of Stau1 55 to TAR-bearing transcripts may (i) facilitate transport and positioning of the transcripts on the ribosomes, (ii) destabilize the TAR RNA structure, allowing binding of eIF4E and/or (iii) facilitate interaction between co-factors, the TAR structure and the ribosomes. Therefore, our working hypothesis is that Stau1 55 first binds selected RNAs and facilitates their transport and positioning on the ribosomes through its capacity to associate with ribosomes. Then, Stau1 55 -and/or Stau1 55 -associated proteins may help to destabilize the 5 0 end structure leading to better interaction with translation initiation factors, such as eIF4E and/or the translational machinery. This effect would allow more ribosomes to be bound to the transcript (Figure 8 ) and consequently should increase translation. Among putative cofactors, helicases are known to influence translation of mRNAs containing secondary structures at their 5 0 ends, helping to disrupt the secondary structures and to translocate the RNA within the polysomes (42, (54) (55) (56) (57) . Moreover, they are frequently associated with RNA-binding proteins (58, 59) . At least two RNA helicases, RHA and La autoantigen, were shown to bind the TAR RNA element and influence TARmediated transcription and translation, respectively (35, 42) . Interestingly, RHA was identified in two independent proteomic analyses of Stau1-containing complexes (27, 28) . While it would also be interesting to test if direct binding of Stau1 55 to ribosomes is required for its function on translation, all of the Stau1 mutations tested to date that prevent Stau1 55 -ribosome association also impair Stau1 55 RNAbinding activity (26) .
Alternatively, Stau1 55 through its observed association with the 60S ribosomal subunit (26) may directly modify ribosomal activity, favouring the joining of the 60S ribosomal subunit to the translation initiation complex and/or influencing translational elongation. Stau1 55 may also interact with chaperones that facilitate proper folding of nascent proteins thus increasing the translation elongation rate or it may interfere with the association of trans-acting protein repressors to 3 0 -or 5 0 -UTR of RNA. The former hypothesis is not likely since the same protein is translated from TAR-Rluc and Rluc transcripts. In Drosophila, Staufen protein was shown to be essential for the translational de-repression of oskar mRNA once properly localized in the oocyte (10, 18) . Translational repression of oskar mRNA depends on functional association of proteins that bind both its 3 0 -and 5 0 -UTR (10,60-62) and on protein involved in the stabilization of the nascent protein (63) . Interestingly, the 5 0 -UTR of oskar mRNA contains an RNA sequence/element that is required for its translational de-repression when localized at the posterior pole (60) .
What is the biological relevance of Staufen in translational regulation? Proteomic (25, 27, 28, 64) and cell biology (21) (22) (23) (24) 65) experiments clearly establish that Stau1 is a component of the RNA transport machinery in several cell types. In neurons, Stau1 granules also contain RNAs and move in dendrites on microtubules (23, 24) , suggesting that Stau1 function might be linked to mRNA transport. This conclusion is supported by the observation that the down-regulation of Stau1 by siRNA reduces the amounts of RNA in dendrites of neurons (25) . While the exact role of Staufen has yet to be defined, it is clear that Stau1 55 plays multiple role(s) in cells in addition to its role in RNA transport. Stau1 55 is associated with telomerase and/or telomeric RNA in the nucleolus (66, 67) , suggesting that it has nuclear function. In the cytoplasm, Stau1 55 regulates RNA stability (52) and it can also regulate translation of a subpopulation of transcripts (this paper). These functions may all be complementary to its putative role in RNA transport such that in both RNA transport granules and stress granules, translation is known to be repressed (68) (69) (70) and it must resume once the transcripts are localized or when physiological conditions are returned to normal. 
